Method of preventing peripheral neuropathies induced by anticanc

Details Method of preventing peripheral neuropathies induced by anticanc Method of preventing peripheral neuropathies induced by anticanc

1994-10-24

1997-07-29

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514449, 514283, 424649, A61K 31445, A61K 31335, A61K 3144, A61K 3324

Patent

active

056522487

ABSTRACT:
Eliprodil, or an enantiomer thereof, is indicated for combined administration with anticancer agents in order to prevent peripheral neuropathies induced by administration of the anticancer agents.

REFERENCES:
patent: 4690931 (1987-09-01), Wick et al.
Merck Index, 11th Ed., Merck & Co, Inc, Rahway, N.J., 1989, p. 1435.
Lipton et al, Neurology, vol. 39, pp. 368-373 (1989) Applicants should provide a copy of this reference.

Affiliated with

Also associated with

Rating

Method of preventing peripheral neuropathies induced by anticanc does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of preventing peripheral neuropathies induced by anticanc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing peripheral neuropathies induced by anticanc will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-634024